SIC
TEVA icon

SJS Investment Consulting’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

SJS Investment Consulting’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39K Hold
100
– – ﹤0.01% 1550
2026
Q1 		$3.01K Hold
100
– – ﹤0.01% 1175
2025
Q4 		$3.12K Buy
+100
New +$2.46K ﹤0.01% 1039
2022
Q1 		$1K Hold
130
– – ﹤0.01% 637
2021
Q4 		$1K Buy
+130
New +$1.17K ﹤0.01% 512

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

SJS Investment Consulting's TEVA Position: Q2 2026 in Review

SJS Investment Consulting held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 100 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1550.

SJS Investment Consulting first reported a position in TEVA in Q4 2021 and has held it in 5 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • SJS Investment Consulting held 100 shares of Teva Pharmaceutical Industries Limited worth $3.39K as of Q2 2026.
  • SJS Investment Consulting left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1550 holding.
  • SJS Investment Consulting first reported a position in Teva Pharmaceutical Industries Limited in Q4 2021 and has held it in 5 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.